MiMedx Group – (NASDAQ:MDXG)

MiMedx Group (NASDAQ:MDXG) Rating Reaffirmed New York: In analysts note announced on 18 December, Canaccord Genuity maintained their Buy rating on MiMedx Group (NASDAQ:MDXG) shares….

MiMedx Group (NASDAQ:MDXG) Rating Reaffirmed They currently have a $12.0 target on MiMedx Group (NASDAQ:MDXG). The target price by Canaccord Genuity would suggest a potential…

MiMedx Group (NASDAQ:MDXG) Rating Reaffirmed Recently, In a comprehensive report announced on Friday, 18 December, MiMedx Group (NASDAQ:MDXG) shares have had their Buy Rating reaffirmed…